Report Details

Canine Oral Chewable Tablets Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2019 to 2025

ID : 7745321
Date : May 2019
Pages : 221 Pages
Industry : Food and Beverages


Global Canine Oral Chewable Tablets Market

Canine Oral Chewable Tablets Market are the oral dosage form of medication with additives used to treat various types of canine diseases such as arthritis, canine congestive heart failure, tick and fleas infections, and among others. Various additives and flavouring agents are used in the formulation of canine oral chewable tablets for masking the unpleasant taste and odour of the drugs. The canine oral chewable tablets will dissolve in 2-5 minutes and the pharmacological action takes place immediately.

The global canine oral chewable tablets market is growing at a significant CAGR due to increase in the adoption of canines. Rise in the expenditure in animal welfare and wellness, wider availability of the canine oral chewable tablets in the market, and rise in the prevalence of various canine diseases such as tick and fleas infections, anticipated to fuel the canine oral chewable tablets market over the forecast period. In addition, ease of administration of tablets compared with parenteral formulations, lack of nutrition values in the canine feed, and initiations taken by various pet organizations and NGOs for animal welfare are expected bolster the canine oral chewable tablets market over the forecast years. However, stringent regulatory policies for the approval of veterinary formulations, lack of awareness about the canine oral chewable tablets in rural areas, high cost of the products, and withdrawn of drugs from the market such as levothyroxine sodium due to FDA warning regarding the lack of approval might hinder the canine oral chewable tablets market growth in the coming future.

The Canine Oral Chewable Tablets Market is segmented on the basis of composition type, drug class, product availability, and distribution channel

Based on the composition type, Canine Oral Chewable Tablets Market is segmented into the following:
Botanically synthesized
Chemically synthesized

Based on the drug class, Canine Oral Chewable Tablets Market is segmented into the following:
Analgesics
Anti-infective
Anti-ulcers
Vitamins & minerals
Cardiovascular drugs
Others

Based on the application, canine oral chewable tablets market is segmented into the following:
Gastrointestinal diseases
Cardiovascular disorders
Infectious diseases
Nutritional supplements
Others

Based on the product type, canine oral chewable tablets market is segmented into the following:
Prescription
Over the Counter OTC

Based on the distribution channel, Canine Oral Chewable Tablets Market is segmented into the following:
Veterinary clinics
Veterinary Pharmacies
Online veterinary stores
Others

The global canine oral chewable tablets market is in the developing stage as several local and international players are actively engaged in the manufacturing of canine oral chewable tablets for the treatment of chronic canine diseases. Acquisitions and mergers, collaborations, joint ventures, and product launches, are some key strategies followed by the manufacturers for increasing their share in the canine oral chewable tablets market. For instance, in December 2015, Boehringer Ingelheim acquired Merial Sanofi animal health for strengthening its product portfolio. In addition, in May 2014, Merck Animal Health received the FDA approval for its drug Bravecto fluralaner used in the treatment of fleas and ticks infections. Moreover, in December 2014, Putney, Inc. launched the Carprofen canine oral chewable tablets for the treatment of pain and inflammation.

Geographically, canine oral chewable tablets market is segmented into the following regions Viz. Europe, Latin America, Asia Pacific, North America, and the Middle East and Africa. North America holds a significant share in global canine oral chewable tablets owing to increase in the adoption of canines according to American Pet Products Association, approximately 78 Mn canines were owned in the U.S., rise in the awareness of canine’s health, growth in the expenditure on animal welfare, increase in the research and development activities for the innovation of new products for chronic canine diseases might fuel the canine oral chewable tablets market in the region. Asia Pacific accounts for key share, which is attributed to increasing in the prevalence of various canine microbial diseases due to unhygienic conditions, a rise in the expenditure on animal welfare, and diversification of business segment in Asia Pacific region by various manufacturers might bolster the canine oral chewable tablets market in Asia Pacific region. Europe holds a major share owing to increase the awareness about pet’s health, a rise in the prevalence of various canine diseases, lack of nutrition fortified canine feed, and rise in research and development activities for the canine oral chewable tablets market might propel the market growth in Europe region.

Some of the players in canine oral chewable tablets market are Zoetis, Inc. Pfizer U.S, Virbac AH Inc. France, Elanco Eli Lilly and Co. U.S., Boehringer Ingelheim vetmedica, Inc. Boehringer Ingelheim Germany, Pala-Tech Laboratories U.S., Bayer HealthCare LLC, Bayer AG Germany, Merck Animal Health Merck &co. Inc. U.S., and Putney, Inc. Dechra Pharmaceuticals U.K. to name a few.
In February 2016, Zoetis Inc. received the FDA approval for Simparica, canine oral chewable tablets for the treatment of ticks and fleas infection
In March 2016, Virbac launched Movoflextm soft chews, as the canine joint health supplementation in the U.S.


Report Outline:
The report provides granular level information about the market size, regional market share, and forecast from 2019-2025
The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
The report tracks recent innovations, key developments, and startup’s details that are working in the industry
1. Executive summary
2. Global Canine Oral Chewable Tablets Market Introduction
2.1. Global Canine Oral Chewable Tablets Market– Taxonomy
2.2. Global Canine Oral Chewable Tablets Market–Definitions
2.2.1. Composition Type
2.2.2. Drug Class
3. Global Canine Oral Chewable Tablets Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Canine Oral Chewable Tablets Market Dynamics – Factors Impact Analysis
3.6. Global Canine Oral Chewable Tablets Market– Recent Market Introductions
4. Global Canine Oral Chewable Tablets Market Analysis, 2014 - 2018 and Forecast, 2019 – 2025
4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
4.2. Year-over-Year Y-o-Y Growth Analysis %
4.3. Market Oppurtunity Analysis
5. Global Canine Oral Chewable Tablets Market Forecast, By Composition Type, 2014 - 2018 and Forecast, 2019 - 2025
5.1. Botanically Synthesized
5.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
5.1.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
5.1.3. Market Opportunity Analysis
5.2. Chemically Synthesized
5.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
5.2.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
5.2.3. Market Opportunity Analysis
6. Global Canine Oral Chewable Tablets Market Forecast, By Drug Class, 2014 - 2018 and Forecast, 2019 - 2025
6.1. Analgesics
6.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
6.1.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
6.1.3. Market Opportunity Analysis
6.2. Anti-infective
6.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
6.2.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
6.2.3. Market Opportunity Analysis
6.3. Anti-ulcers
6.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
6.3.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
6.3.3. Market Opportunity Analysis
6.4. Vitamins & Minerals
6.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
6.4.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
6.4.3. Market Opportunity Analysis
6.5. Cardiovascular Drugs
6.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
6.5.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
6.5.3. Market Opportunity Analysis
6.6. Others
6.6.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
6.6.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
6.6.3. Market Opportunity Analysis
7. Global Canine Oral Chewable Tablets Market Forecast, By Application, 2014 - 2018 and Forecast, 2019 - 2025
7.1. Gastrointestinal Diseases
7.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
7.1.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
7.1.3. Market Opportunity Analysis
7.2. Cardiovascular Disorders
7.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
7.2.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
7.2.3. Market Opportunity Analysis
7.3. Cardiovascular Disorders
7.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
7.3.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
7.3.3. Market Opportunity Analysis
7.4. Cardiovascular Disorders
7.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
7.4.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
7.4.3. Market Opportunity Analysis
7.5. Others
7.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
7.5.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
7.5.3. Market Opportunity Analysis
8. Global Canine Oral Chewable Tablets Market Forecast, By Distribution Channel, 2014 - 2018 and Forecast, 2019 - 2025
8.1. Veterinary Clinics
8.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
8.1.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
8.1.3. Market Opportunity Analysis
8.2. Veterinary Pharmacies
8.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
8.2.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
8.2.3. Market Opportunity Analysis
8.3. Online Veterinary Pharmacies
8.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
8.3.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
8.3.3. Market Opportunity Analysis
8.4. Others
8.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
8.4.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
8.4.3. Market Opportunity Analysis
9. Global Canine Oral Chewable Tablets Market Forecast, By Region, 2014 - 2018 and Forecast, 2019 - 2025
9.1. North America
9.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
9.1.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
9.2.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
9.3.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
9.4.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
9.5.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
9.5.3. Market Opportunity Analysis
9.6. Global Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Region, 2019 – 2025
10. North America Canine Oral Chewable Tablets Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
10.1.1. Composition Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
10.1.1.1. Botanically Synthesized
10.1.1.2. Chemically Synthesized
10.1.2. Drug Class Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
10.1.2.1. Analgesics
10.1.2.2. Anti-infective
10.1.2.3. Anti-ulcers
10.1.2.4. Vitamins & Minerals
10.1.2.5. Cardiovascular Drugs
10.1.2.6. Others
10.1.3. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
10.1.3.1. Gastrointestinal Diseases
10.1.3.2. Cardiovascular Disorders
10.1.3.3. Infectious Diseases
10.1.3.4. Nutritional Supplements
10.1.3.5. Others
10.1.4. Distribution Channel Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
10.1.4.1. Veterinary Clinics
10.1.4.2. Veterinary Pharmacies
10.1.4.3. Online Veterinary Pharmacies
10.1.4.4. Others
10.1.5. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn Y-o-Y Growth % and Market Share %
10.1.5.1. U.S.
10.1.5.2. Canada
10.1.6. North America Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2019 – 2025
10.1.7. North America Canine Oral Chewable Tablets Market Dynamics – Trends
11. Europe Canine Oral Chewable Tablets Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
11.1.1. Composition Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
11.1.1.1. Botanically Synthesized
11.1.1.2. Chemically Synthesized
11.1.2. Drug Class Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
11.1.2.1. Analgesics
11.1.2.2. Anti-infective
11.1.2.3. Anti-ulcers
11.1.2.4. Vitamins & Minerals
11.1.2.5. Cardiovascular Drugs
11.1.2.6. Others
11.1.3. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
11.1.3.1. Gastrointestinal Diseases
11.1.3.2. Cardiovascular Disorders
11.1.3.3. Infectious Diseases
11.1.3.4. Nutritional Supplements
11.1.3.5. Others
11.1.4. Distribution Channel Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
11.1.4.1. Veterinary Clinics
11.1.4.2. Veterinary Pharmacies
11.1.4.3. Online Veterinary Pharmacies
11.1.4.4. Others
11.1.5. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
11.1.5.1. Germany
11.1.5.2. UK
11.1.5.3. France
11.1.5.4. Spain
11.1.5.5. Italy
11.1.5.6. Russia
11.1.5.7. Poland
11.1.5.8. Rest of Europe
11.1.6. Europe Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2019 – 2025
11.1.7. Europe Canine Oral Chewable Tablets Market Dynamics – Trends
12. Asia-Pacific Canine Oral Chewable Tablets Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
12.1.1. Composition Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
12.1.1.1. Botanically Synthesized
12.1.1.2. Chemically Synthesized
12.1.2. Drug Class Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
12.1.2.1. Analgesics
12.1.2.2. Anti-infective
12.1.2.3. Anti-ulcers
12.1.2.4. Vitamins & Minerals
12.1.2.5. Cardiovascular Drugs
12.1.2.6. Others
12.1.3. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
12.1.3.1. Gastrointestinal Diseases
12.1.3.2. Cardiovascular Disorders
12.1.3.3. Infectious Diseases
12.1.3.4. Nutritional Supplements
12.1.3.5. Others
12.1.4. Distribution Channel Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
12.1.4.1. Veterinary Clinics
12.1.4.2. Veterinary Pharmacies
12.1.4.3. Online Veterinary Pharmacies
12.1.4.4. Others
12.1.5. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn,
Y-o-Y Growth %, and Market Share %
12.1.5.1. Japan
12.1.5.2. China
12.1.5.3. India
12.1.5.4. ASEAN
12.1.5.5. Australia & New Zealand
12.1.5.6. Rest of Asia-Pacific
12.1.6. Asia-Pacific Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2019 – 2025
12.1.7. Asia-Pacific Canine Oral Chewable Tablets Market Dynamics – Trends
13. Latin America Canine Oral Chewable Tablets Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
13.1.1. Composition Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
13.1.1.1. Botanically Synthesized
13.1.1.2. Chemically Synthesized
13.1.2. Drug Class Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
13.1.2.1. Analgesics
13.1.2.2. Anti-infective
13.1.2.3. Anti-ulcers
13.1.2.4. Vitamins & Minerals
13.1.2.5. Cardiovascular Drugs
13.1.2.6. Others
13.1.3. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
13.1.3.1. Gastrointestinal Diseases
13.1.3.2. Cardiovascular Disorders
13.1.3.3. Infectious Diseases
13.1.3.4. Nutritional Supplements
13.1.3.5. Others
13.1.4. Distribution Channel Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
13.1.4.1. Veterinary Clinics
13.1.4.2. Veterinary Pharmacies
13.1.4.3. Online Veterinary Pharmacies
13.1.4.4. Others
13.1.5. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
13.1.5.1. Brazil
13.1.5.2. Mexico
13.1.5.3. Argentina
13.1.5.4. Venezuela
13.1.5.5. Rest of Latin America
13.1.6. Latin America Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2019 – 2025
13.1.7. Latin America Canine Oral Chewable Tablets Market Dynamics – Trends
14. Middle East & Africa Canine Oral Chewable Tablets Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
14.1.1. Composition Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
14.1.1.1. Botanically Synthesized
14.1.1.2. Chemically Synthesized
14.1.2. Drug Class Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
14.1.2.1. Analgesics
14.1.2.2. Anti-infective
14.1.2.3. Anti-ulcers
14.1.2.4. Vitamins & Minerals
14.1.2.5. Cardiovascular Drugs
14.1.2.6. Others
14.1.3. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
14.1.3.1. Gastrointestinal Diseases
14.1.3.2. Cardiovascular Disorders
14.1.3.3. Infectious Diseases
14.1.3.4. Nutritional Supplements
14.1.3.5. Others
14.1.4. Distribution Channel Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
14.1.4.1. Veterinary Clinics
14.1.4.2. Veterinary Pharmacies
14.1.4.3. Online Veterinary Pharmacies
14.1.4.4. Others
14.1.5. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth %, and Market Share %
14.1.5.1. Gulf Cooperation Council GCC Countries
14.1.5.2. Israel
14.1.5.3. South Africa
14.1.5.4. Rest of MEA
14.1.6. MEA Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2019 – 2025
14.1.7. MEA Canine Oral Chewable Tablets Market Dynamics – Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis
15.2.1. Zoetis, Inc. Pfizer U.S
15.2.2. Virbac AH Inc. France
15.2.3. Elanco Eli Lilly and Co. U.S.
15.2.4. Boehringer Ingelheim vetmedica, Inc. Boehringer Ingelheim Germany
15.2.5. Pala-Tech Laboratories U.S.
15.2.6. Bayer HealthCare LLC, Bayer AG Germany
15.2.7. Merck Animal Health Merck &co. Inc. U.S.
15.2.8. Putney, Inc. Dechra Pharmaceuticals U.K.
16. Research Methodology
17. Key Assumptions and Acronyms


Please fill the following form to know more details about this Report




RELATED PRODUCTS



CHOOSE A FORMAT


  •  Single User Price : $ 4400
  •  Enterprise User License : $ 6600
  •  Corporate User License : $ 8900

Have A Question ?


  DOWNLOAD SAMPLE



TESTIMONIALS

I am completely satisfied with the information given in the sample pages of the report and I am waiting for the affirmative response from my peers and colleagues to purchase it.hey answered to all my queries promptly. I am highly satisfied!!
John Keats
We received a very quick response to all our queries on the RTLS report and we were also given a free consult with analyst for 15 minutes. It is refreshing (and increasingly rare) to have a new company go the extra mile to win the confidence of the customer
Ernest Hemingway
I would like to express my gratitude for the excellent service received this morning from the support team. They acknowledged my concern of adding me to the secondary user's list immediately. Thank you for this excellent, speedy and thoughtful service
Jacob Watson

CUSTOM RESEARCH

Still haven't found what you're looking for ?
Speak to our Custom Research Team